Tuberculosis: Promising new tuberculosis drug pretomanid approved, but will it be affordable?

August 15, 2019

GENEVA/NEW YORK – Doctors Without Borders/Médecins Sans Frontières (MSF) welcomes the approval by the US Food and Drug Administration (FDA) of a combination regimen containing a new drug, pretomanid, for the treatment of extensively drug-resistant tuberculosis (XDR-TB). As the third...

Manipur: Providing patient-centered HIV, TB, and hepatitis care to patients

July 30, 2019

When Thongsei Lupho, 44, first started feeling unwell, he suspected he had contracted Tuberculosis. He visited MSF’s clinic in Moreh, on the Indo-Myanmar border, where he was diagnosed with HIV. Lupho had used drugs in the past to gain social...

World Tuberculosis Day: Treating the untreatable

March 24, 2019

With 84,000 cases of drug-resistant tuberculosis, India has the highest burden of DR-TB in the world. In Mumbai, MSF has been providing not just medical treatment but holistic care to people living with DR-TB. Watch this video to find out...

Tuberculosis: TB activists challenge Johnson & Johnson patent application on bedaquiline in India

February 14, 2019

Mumbai/Cape Town - Doctors Without Borders/Médecins Sans Frontières (MSF) is supporting a patent challenge filed in India this week by two tuberculosis survivors, to prevent pharmaceutical corporation Johnson & Johnson (J&J) from extending its monopoly on the tuberculosis drug bedaquiline. Nandita...

Tuberculosis: TB activists challenge Johnson & Johnson patent application on bedaquiline in India

February 8, 2019

Mumbai/Cape Town - Doctors Without Borders/Médecins Sans Frontières (MSF) is supporting a patent challenge filed in India this week by two tuberculosis survivors, to prevent pharmaceutical corporation Johnson & Johnson (J&J) from extending its monopoly on the tuberculosis drug bedaquiline....

Renewed hope- Stories of four patients fighting drug-resistant-TB in Mumbai

March 24, 2018

Name : Designation : Interviews conducted & written by DVL Padma Priya for MSF For World TB Day 2018, we celebrate the courage and endurance of four MSF patients who are currently undergoing treatment for drug-resistant TB (DR-TB). Pooja,...

MSF: India’s decision to give Pfizer unmerited patent on lifesaving pneumonia vaccine limits access for children globally

November 20, 2017

At High Court of Delhi hearing tomorrow, Doctors Without Borders/Médecins Sans Frontières (MSF) will urge India to remain the “pharmacy of the developing world” and rethink decision that solidifies Pfizer monopoly on critical pneumonia vaccine New York/ New Delhi, November 20, 2017 —...

India skips 6 Of 16 key WHO recommendations on TB

August 12, 2017

India does not implement six out of the 16 key World Health Organisation (WHO)- recommended tuberculosis (TB) control policies in diagnosis, patient care and treatment, a new global report has found. Four other policies that are a part of the national policy...

Mumbai: A new life with new tuberculosis drugs

December 1, 2016

Increasingly drug-resistant strains of tuberculosis (TB) are on the rise in India, particularly in hotspots such as Mumbai. Two new TB drugs, bedaquiline and delaminid, show promising results and offer renewed hope to patients whose TB strains are resistant to...

India: Renewed hope with new drugs

October 28, 2016

Two new drugs, bedaquiline and delamanid, are proving to be the very last lifeline for tuberculosis (TB) patients with the most extreme forms of drug resistance. While a few patients benefit from these new drugs in India, many die before being able...